Suchergebnisse - "Pérez-de-Llano, Luis"

PubPharm (9)

1

Reply to "Exploring the long-term effects of biologic initiation in severe asthma : Insights from the International Severe Asthma Registry"

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Chen, W. | Tran, T. | Sadatsafavi, M. | +62

2

Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

enthalten in: American journal of respiratory and critical care medicine | 2024

von Wechsler, M. | Scelo, G. | Larenas-Linnemann, D. | +83

CommentIn: Am J Respir Crit Care Med. 2024 Feb 1;209(3):233-235. - PMID 38064716

3

Redefining the Role of Bronchoscopy in the Workup of Severe Uncontrolled Asthma in the Era of Biologics : A Prospective Study

enthalten in: Chest | 2023

von Cosío, B. | Shafiek, H. | Mosteiro, M. | +7

4

Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER) : Data From the International Severe Asthma Registry

enthalten in: The journal of allergy and clinical immunology. In practice | 2023

von Chen, W. | Tran, T. | Sadatsafavi, M. | +62

CommentIn: J Allergy Clin Immunol Pract. 2024 Feb;12(2):535-536. - PMID 38336402

5

Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

enthalten in: Allergy | 2023

von Pfeffer, P. | Ali, N. | Murray, R. | +66

6

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Porsbjerg, C. | Menzies-Gow, A. | Tran, T. | +56

ErratumIn: J Allergy Clin Immunol Pract. 2022 Jun;10(6):1673. - PMID 35688511

7

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Beltran, J. | Akdis, C. | +31

8

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma : A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Rocha, C. | Beltran, J. | +31

9

Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

enthalten in: Allergy | 2020

von Agache, I. | Song, Y. | Rocha, C. | +31

1
[1]